Investor Presentaiton

5 year Division wise Revenue Contribution Generic 2% 7% 9% 10% FDF 3% 13% 8% 8% 8% 29% 6% 9% 38% 8% Custom 10% Synthesis 14% 10% Other API 11% 11% 7% 82% 77% 74% 7% 66% Onco API Anti Viral ΑΡΙ 39% 34% FY 16 FY 17 FY 18 FY 19 FY 20 FY 21 H1 9 LAURUS Labs Knowledge Innovation. Excelence

View entire presentation